Fifth Third Bancorp Enanta Pharmaceuticals Inc Transaction History

Fifth Third Bancorp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$11.09 - $22.13 $3,759 - $7,502	339 Added 1784.21%	358 $3,000
Q2 2023 Jul 25, 2023	SELL	$20.68 - $39.85 $517 - $996	-25 Reduced 56.82%	19 $0
Q2 2022 Aug 04, 2022	SELL	$38.13 - $76.93 $686 - $1,384	-18 Reduced 29.03%	44 $2,000
Q1 2022 Apr 19, 2022	SELL	$56.06 - $74.11 $112 - $148	-2 Reduced 3.13%	62 $4,000
Q4 2021 Feb 01, 2022	BUY	$60.19 - $97.37 $2,708 - $4,381	45 Added 236.84%	64 $5,000
Q3 2021 Oct 15, 2021	BUY	$41.02 - $58.65 $779 - $1,114	19 New	19 $1,000
Q4 2019 Feb 14, 2020	SELL	$57.95 - $66.61 $1,622 - $1,865	-28 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $1,682 - $2,468	28 New	28 $2,000

107

18.3M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $148M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.